ALEMBIC PHARMACEUTICALS LTD. - Press Release
15 May 2017
With reference to the captioned subject, this is to inform the exchange that the Company has received U.S. Food & Drug Administration (FDA) approval for Fenofibric Acid Delayed-Release Capsules. Please find enclosed herewith our press release. We request you to kindly take the same on record.
Source:
BSE India